Hasil Pencarian - Frédéric Pinguet

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management

    FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management oleh Isabelle Solassol, Frédéric Pinguet, Xavier Quantin

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    New advances in DPYD genotype and risk of severe toxicity under capecitabine.

    New advances in DPYD genotype and risk of severe toxicity under capecitabine. oleh Marie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Christophe Beroud, Litaty Mbatchi, André van Kuilenburg, Christine Bobin-Dubigeon, Fabienne Thomas, Etienne Chatelut, Jean-Louis Merlin, Frédéric Pinguet, Christophe Ferrand, Judith Meijer, Alexandre Evrard, Laurence Llorca, Gilles Romieu, Philippe Follana, Thomas Bachelot, Loic Chaigneau, Xavier Pivot, Véronique Dieras, Rémy Largillier, Mireille Mousseau, Anthony Goncalves, Henri Roché, Jacques Bonneterre, Véronique Servent, Nadine Dohollou, Yann Château, Emmanuel Chamorey, Jean-Pierre Desvignes, David Salgado, Jean-Marc Ferrero, Gérard Milano

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: